Further, half maximal inhibitory concentration confirmed the effect of ZNF765 expression on the sensitivity of hepatocellular carcinoma cells to effective docetaxel and bleomycin used in the treatment of patients with hepatocellular carcinoma. The gene discussed is ZNF765; the disease is hepatocellular carcinoma.